The phoenix is a mythical bird symbolizing immortality, resurrection, and vitality. Inspired by this emblem, Ginza Houou Clinic develops and offers cellular therapies designed to address cancer, intractable diseases, and aging at their root cause.
Specializing in cancer immunotherapy and stem cell treatments, our clinic provides "composite cancer immunotherapy," a low-burden, low-side-effect treatment particularly tailored for terminal cancer patients. This therapy is designed to be effective regardless of cancer type or stage.
In the field of stem cell treatment, we address a wide range of conditions, including diabetes, arteriosclerosis, chronic pain, knee joint issues, skin rejuvenation, and even hair loss.
The key to successful cellular therapy lies in the *quality of cells*. At our clinic, we house one of the largest in-house cell culture centers in Japan, allowing us to handle the entire process of cell harvesting, culturing, and administration under one roof. This ensures the delivery of the highest-quality, most active cells to our patients.
specialized field
Cancer Immunotherapy
Adipose-Derived Stem Cell Therapy
The clinic has obtained regenerative medicine provision plan numbers from the Ministry of Health, Labour and Welfare, Japan, as follows:
Second Class Regenerative Medicine Plans
1. Manufacturing Notification for Specified Cell Processed Products: FC3230006
2. Treatment for Diabetes and Borderline Diabetes using Autologous Adipose-Derived Mesenchymal Stem Cells: Plan No. PB3240165
3. Treatment for Chronic Pain using Autologous Adipose-Derived Mesenchymal Stem Cells: Plan No. PB3230241
4. Treatment for Arteriosclerosis using Autologous Adipose-Derived Mesenchymal Stem Cells: Plan No. PB3240111
5. Treatment for Osteoarthritis using Autologous Adipose-Derived Stem Cells: Plan No. PB3240110
6. Treatment for Age-Related Skin Changes (Wrinkles and Sagging) using Autologous Adipose-Derived Mesenchymal Stem Cells: Plan No. PB3230240
7. Treatment for Age-Related Hair Changes using Autologous Adipose-Derived Mesenchymal Stem Cells: Plan No. PB3230238
8. Treatment for Chronic Pain using Autologous Adipose-Derived Stem Cells: Plan No. PB3230041
9. Treatment for Osteoarthritis using Autologous Adipose-Derived Stem Cells: Plan No. PB3230042
10. Treatment for Hair Tissue Disorders using Autologous Adipose-Derived Stem Cells: Plan No. PB3230119
11. Facial Atrophy and Skin Regeneration Treatment using Autologous Adipose-Derived Stem Cells: Plan No. PB3230120
Third Class Regenerative Medicine Plans
1. Immune Function Enhancement Therapy for Cancer using Dendritic Cells: Plan No. PC3220088
2. Natural Killer (NK) Cell Therapy for Malignant Tumors: Plan No. PC3230088
3. Activated Lymphocyte Therapy for Malignant Tumors: Plan No. PC3230089
4. Immune Function Enhancement Therapy for Cancer using NKT Cell-Activated Dendritic Cells: Plan No. PC3230128
5. Immune Function Enhancement Therapy for Cancer using NKT Cell-Activated Dendritic Cells: Plan No. PC3230277
6. Dendritic Cell Vaccine Therapy for Malignant Tumors: Plan No. PC3220021
7. Immune Function Enhancement Therapy for Cancer using NK Cells: Plan No. PC3220052
8. Immune Function Enhancement Therapy for Cancer using αβT Cells: Plan No. PC3220053
These designations underscore the clinic's compliance with regulatory standards and its commitment to delivering advanced regenerative and immunotherapy treatments.
sales point
Location
- A 2-minute walk from JR Akihabara Station, located in the landmark UDX Building.
Medical and Diagnostic Equipment
- Optia: Equipment for apheresis and component blood collection.
On-Site Facilities
- Equipped with one of the largest in-house cell culture centers (Cell Culture Processing Center).
for more details information about this program, kindly inquire from here